User:Yl2087/Semaglutide

In 2022, a clinical trial conducted among adolescents with obesity was found that once-weekly treatment with a 2.4-mg dose of semaglutide, when added to lifestyle intervention, led to a greater reduction in BMI as compared to lifestyle intervention alone.